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In the coronary care unit we group patients into typical categories, such as ischemic, heart failure, or arrhythmia admissions. Such simplification is natural and helpful in remembering the correct patient and communicating with other providers. The coding of diagnoses with each clinic visit reinforces the association of the patient with 1 or perhaps a few conditions depending on how impatient we are with our electronic medical record. Although this is a useful way to track patients for population health this labeling overestimates the importance of the condition to the individual.
In this issue of JACC: Heart Failure, Joyce et al. (1) show how "heart failure patients" often do not think heart failure is their main problem. The investigators from Brigham and Women's Hospital examined the contribution of heart failure to quality of life among patients in their heart failure clinic. Clearly heart failure is an important medical condition for these patients given that they chose to attend a clinic specializing in heart failure at a major tertiary referral center. However, only one-half of the patients with heart failure said their quality of life was primarily limited by heart failure symptoms. In the other half noncardiac and nonmedical problems were equally or more important.
Although their results should be generalizable to other heart failure clinics, the findings may be even more striking for patients followed only in primary care. The mean age of the patients in the current study was 56 years and primary care patients are likely to be 15 years older on average. Those patients with heart failure who are not referred to a heart failure clinic have more comorbidities and less severe heart failure. It is reasonable to assume that heart failure is usually not the most important issue impacting their quality of life.
Still, for one-half the patients in the Joyce study, heart failure was the major contributor to poor quality of life. We know that heart failure-specific health status and overall quality of life are often markedly depressed with heart failure. Two common measures of overall quality of life are the Short Form Questionnaire (e.g., SF-36) and a utility measurement. The health. Clearly those with heart failure are suffering, and for many, the symptoms of heart failure are the reason. A recent study compared overall quality of life with a heart failure-specific measure and found that heart failure symptoms were significantly associated with overall quality of life using a utility, but so were other factors including age, gender, and the Charlson score for comorbidities (4) . Without an understanding of the importance of other individual comorbidities we often attribute the entire reduction in quality of life to heart failure.
Economic forecasts may also ignore comorbid conditions. Many analyses of the "impact" of heart 
failure care attribute all medical costs to heart failure for patients with a diagnosis of heart failure. When analyzed in a way that does not allow double counting, a study by the American Heart Association estimated that direct medical costs attributable to heart failure will be $51 billion per year by 2030 (5). Although a substantial sum, the total direct medical costs for these patients will be 3-fold higher ($160 billion). One can see that estimated cost savings will be wildly unrealistic if we simply attribute all costs to a single condition.
Similarly, overattribution leads to inaccurate predictions on how effective heart failure interventions How should we respond to these results? First, researchers should always include an overall measure of health status, ideally a utility measure that estimates the patient's preference for quality of life in addition to a heart failure-specific measure. Heart failure-specific questionnaires are important because they are more sensitive to clinical change and useful in detecting an effect of an intervention's symptoms than overall quality of life questionnaires. However, in choosing interventions that have adequate value we need a measure of overall quality of life that can be compared across diseases and conditions. For the clinician a small step is to describe patients as having heart failure rather than labeling them a heart failure patient.
More importantly, the findings from Joyce et al. (1) argue that a comprehensive, holistic approach is needed. Ideally this is by whomever is providing primary care to the patient with heart failure. I would argue it is beyond the expertise of most heart failure clinics to manage the varied noncardiovascular complaints that are the greatest determinates of quality of life for different patients. This is even a challenge for primary care physicians practicing in a medical home.
One strategy is to consider "palliative" care for all patients with significant symptoms and multiple 
